Two Sigma Investments’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,767,107
Closed -$142M 3591
2016
Q4
$142M Buy
1,767,107
+94,715
+6% +$7.52M 0.54% 22
2016
Q3
$133M Buy
1,672,392
+622,580
+59% +$50.3M 0.48% 38
2016
Q2
$81.9M Sell
1,049,812
-40,403
-4% -$2.88M 0.35% 57
2016
Q1
$60M Buy
1,090,215
+101,089
+10% +$5.51M 0.29% 77
2015
Q4
$61.1M Buy
989,126
+786,461
+388% +$49.6M 0.29% 86
2015
Q3
$12.8M Sell
202,665
-266,517
-57% -$19M 0.07% 310
2015
Q2
$34.3M Sell
469,182
-340,832
-42% -$24.6M 0.16% 159
2015
Q1
$53M Buy
810,014
+146,741
+22% +$9.76M 0.25% 98
2014
Q4
$43.1M Sell
663,273
-186,691
-22% -$12M 0.24% 97
2014
Q3
$51.1M Sell
849,964
-157,283
-16% -$10.3M 0.23% 133
2014
Q2
$69.8M Sell
1,007,247
-135,357
-12% -$8.77M 0.31% 68
2014
Q1
$74.7M Buy
+1,142,604
New +$74.4M 0.4% 50

Other funds holding STJ

Two Sigma Investments's STJ Position: Q1 2017 in Review

Two Sigma Investments sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,767,107 shares — an estimated $142M sold.

Two Sigma Investments first reported a position in STJ in Q1 2014 and held it in 12 quarters. The position peaked at $142M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Two Sigma Investments reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Two Sigma Investments sold 1,767,107 St Jude Medical shares in Q1 2017, an estimated $142M.
  • Two Sigma Investments first reported a position in St Jude Medical in Q1 2014 and held it in 12 quarters.
  • Two Sigma Investments's St Jude Medical position peaked at $142M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Two Sigma Investments's 13F filing for Q1 2017, filed 15 May 2017.